Nova Satra Dx
Singapore
About Nova Satra Dx
Nova Satra Dx is a molecular diagnostics company headquartered in Singapore. The company is committed to empowering patients and physicians through the research, development and commercialisation of novel blood based diagnostic tests. These tests provide rapid and accurate detection of cancer using Asian-specific epigenetic biomarkers. Based on its clinically validated NovoTect™ technology developed by the University of Oxford, Nova Satra’s diagnostic tests can detect and identify changes in gene expression which are linked to cancer. The company is developing a pipeline of tests for breast, colon, prostate, stomach and lung cancers. For more information, please visit www.novasatra.com
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Apr 2017)
- Website: novasatra.com
- Phone: +65 6818 6050
Industries & Categories
Genetics, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/nova-satra-dx-95337 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.